P-118 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: INDICATION FOR LIVER TRANSPLANTATION AND OCCURRENCE IN THE POSTOPERATIVE PERIOD
Conflict of interest: No Introduction and Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most important causes of liver disease worldwide, and it is currently the main indication for liver transplantation.This study aims to evaluate (1) clinical-epidemiolo...
Saved in:
Main Authors: | Felipe Ramos Caprini, Guilherme Massote Fontanini, Juarez Roberto de Oliveira Vasconcelos, Fernanda Fernandes Souza, Ajith Kumar Sankarankutty, Marcia Guimarães Villanova, Roberta Chaves Araújo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | Annals of Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268124005155 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
P-85 IMPACT OF TECHNICAL NOTE No 32/2021 ON THE RATE OF LIVER TRANSPLANTS FOR REFRACTORY ASCITIS IN A TERTIARY HOSPITAL
by: Guilherme Massote Fontanini, et al.
Published: (2024-12-01) -
Insulin resistance has closer correlation with the occurrence of metabolic dysfunction associated steatotic liver disease diagnosed by liver biopsy
by: Weihua Cao, et al.
Published: (2024-11-01) -
Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01) -
Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Jessica M. Rubino, et al.
Published: (2025-01-01) -
Microbiota and metabolic dysfunction associated with steatotic liver disease
by: Q. Zhu, et al.
Published: (2024-09-01)